Abnormal laboratory findings review in SARS-CoV-2 infection
DOI:
https://doi.org/10.33448/rsd-v11i5.28793Keywords:
COVID-19; SARS-CoV-2; Laboratory tests; Health teaching.Abstract
COVID-19 can trigger damage to the function and integrity of multiple cells, tissue or organs. In the progression of clinical manifestations, laboratory biomarkers can be used as predictors of prognosis to support in clinical conduction. This study aims to evidence an updated review of the literature of changes in biochemical and hematological laboratory tests of individuals with COVID-19 from articles prospected from the SciELO, LILACS and PubMed databases. Although in severe clinical spectrums, especially in patients admitted to intensive care unit, tissue lesions are more intense and more evident laboratory changes, can be observed in general in patients infected with SARS-CoV-2 increased levels of transaminases, alkaline phosphatase, gamma glutamyl transferase, bilirubin, urea, creatinine, lactic dehydrogenases, amylase, lipase, troponins, NT-ProBNP, pro-BNP, as well as reduction of MCV and MCHC, lymphopenia, neutrophilia, eosinopenia, thrombocytopenia, and prolongation of PT and aPTT.
References
Ahmadian, E., Abediazar, S., Khatibi, S. M. H., Soofiyani, S. R., Abediazar, S., Shoja, M. M., Ardalan, M., & Vahed, S. Z. (2020). COVID‐19 and kidney injury: Pathophysiology and molecular mechanisms, Rev Med Virol, 31 (3), p. 1-13.
Almeida, J. O., Oliveira, V. R. T., Avelar, J. L. S., Moita, B. S., & Lima, L. M. (2020). Covid-19: Fisiopatologia e alvos para intervenção terapêutica, Revista Virtual de Química, 12 (6), 1464-1497.
Babapoor-Farrokhrana, S., Gillb, D., Walkerb, J., Rasekhic, R. T., Bozorgnia, B., & Amanullah A. (2020). Myocardial injury and COVID-19: possible mechanisms, Life Sciences, 253, p. 1-4.
Batschauer, A. P. B., & Jovita, H. W. (2020). Hemostasia e COVID-19: fisiopatologia, exames laboratoriais e terapia anticoagulante, Revista Brasileira de Análises Clínicas. 52(2), 138-42.
Bastug, A., Bodur, H., Erdogan, S., Gokcinar, D., Kazancioglu, S., Kosovali, B. D., Ozbay, B. O., Gok, G., Turan, I. O., Yilmaz, G., Gonen, C. C., & Yilmaz, F. M. (2020). Clinical and laboratory features of COVID-19: Predictors of severe prognosis, International immunopharmacology, 88, 2020.
Blomme, S., Smets, L., Ranst, M. V., Boeckx, N., & Laer, C. V. (2020). The influence of COVID-19 on routine hematological parameters of hospitalized patients, Acta Clinica Belgica, 77 (2), p. 241-246.
Brandão, S. C. S., Godoi, E. T. A. M., Ramos, J. O. X., Melo, L. M. M. P., & Sarinho, E. S. C. (2020). COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica, Jornal Vascular Brasileiro, 19, p. 1-11.
Cândido, R. F. L. (2021). Alterações hematológicas associadas à COVID-19 em pacientes sintomáticos [Monografia, Universidade Federal do Rio Grande do Norte]. Repositório Institucional UFRN. https://repositorio.ufrn.br/handle/123456789/43240
Chagas, G. C. L., Rangel, A. R., Noronha, L. M., Silva Junior, G. B., Meneses, G. C., Martins, A. M. C., & Daher, E. F. (2021). Covid-19 e os rins: uma revisão narrativa, Rev. Bras. Saúde Matern. Infant, 21 (2), p. 383-392.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395 (10223), p. 507-513.
Chen, R., Liang, W., Jiang, M., Guan, W., Zhan, C., Wang, T., Tang, C., Sang, L., Liu, J., Ni, Z., Hu, Y., Liu, L., Shan, H., Lei, C., Peng, Y., Wei, L., Liu, Y., Hu, Y., Peng, P., Wang, J., Liu, J., Chen, Z., Li, G., Zheng, Z., Qiu, S., Luo, J., Ye, C., Zhu, S., Liu, X., Cheng, L., Ye, F., Zheng, J., Zhang, N., Li, Y., He, J., Li, S., & Zhong, N. (2020). Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest, 158 (1), p. 97-105.
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020). Kidney disease is associated with in-hospital death of patients with COVID-19, Kidney International, 97(5), p. 829–838.
Coradi, C., & Vieira, S. L. V. (2021). Alterações leucocitárias em pacientes com COVID-19 observadas em extensão de sangue periférico, Research, Society and Development, 10 (11), p. 1-15.
Cordero, P. M., Crespo, D. O., Caceres, W. S., Choez, K. M., Naunay, D. C., Davila, C. S., Carrillo, A. O., Morocho, G. C., & Calero, J. R. (2020). Lesión pancreática causada por Covid-19:¿ es la diabetes una secuela de la infección?, Diabetes Internacional, 12 (1), p. 34-38, 2020.
Cosic, I., Cosic, D., & Loncarevic, I. (2020). RRM prediction of erythrocyte band 3 protein as alternative receptor for SARS-CoV-2 virus, Applied Sciences, 10 (11), p. 1-9.
Deng, Q., Hu, B., Zhang, Y., Wang, H., Zhou, X., Hu, W., Cheng, Y., Yan, J., Ping, H., & Zhou, Q. (2020). Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China, International Journal of Cardiology, 311, p. 116-121.
Egidio, A. N., Campos, B. N., Junqueira, C. F. S., Martins, F. R., Fabri Junior, J., Rodrigues, J. F., Siqueira, L. G. G., Oliveira, L. R. B., Ferreira, M. B. S., Antunes, V. R. M., & Torres, V. P. (2020). Implicações Cardiovasculares na Covid-19: Uma Revisão Sistemática, Brazilian Journal of Development, 6 (10), p. 82111-82128.
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C., He, J., Liu, L., Shan, H., Lei, C., Hui, D. S. C., Du, B., Li, L., Zeng, G., Yuen, K. Y., Chen, R., Tang, C., Wang, T., Chen, P., Xiang, J., Li, S., Wang, J., Liang, Z., Peng, Y., Wei, L., Liu, Y., Hu, Y., Peng, P., Wang, J., Liu, J., Chen, Z., Li, G., Zheng, Z., Qiu, S., Luo, J., Ye, C., Zhu, S., & Zhong, N. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China, The New England Journal of Medicine, 382 (18), p. 1708-1720.
Guclu, E., Kocayigit, H., Okan, H. D., Erkorkmaz, U., Yurumez, Y., Yaylaci, S., Koroglu, M., Uzun, C., & Karabay, O. (2020). Effect of COVID-19 on platelet count and its indices, Revista da Associação Médica Brasileira, 66 (8), p. 1122-1127.
Han, H., Xie, L., Liu, R., Yang, J., Liu, F., Wu, K., Chen, L., Hou, W., Feng, Y., & Zhu, C. (2020). Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China, Journal of Medical Virology, 92 (7), p. 819–823.
Huang, Y., Tu, M., Wang, S., Chen, S., Zhou, W., Chen, D., Zhou, L., Wang, M., Zhao, Y., Zeng, W., Huang, Q., Xu, H., Liu, Z., & Guo, L. (2020). Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis, Travel medicine and infectious disease, 36, p. 1-3.
Hwaiz, R., Merza, M., Hamad, B., Hamasalih, S., Mohammed, M., & Hama, H. (2021). Evaluation of hepatic enzymes activities in COVID-19 patients, International Immunopharmacology, 97, p. 1-4.
Khawaja, U. A., Shamsoddin, E., Desideri, L. F., & Tovani-Palone, M. R. (2021). Infecção de hemácias por SARS-CoV-2: novas evidências, Einstein, 19, p.1-2.
Kilercik, M., Demirelce, O., Serdar, M., Mikailova, P., & Serteser, M. (2021). A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients, Plos One, 16 (8), p.1-19.
Kratzer, B., Trapin, D., Ettel, P., Körmöczi, U., Rottal, A., Tuppy, F., Feichter, M., Gattinger, P., Brorochova, K., Dorofeeva, Y., Tulaeva, I., Weber, M., Grabmeier-Pfistershammer, K., Tauber, P. A., Gerdov, M., Muhl, B., Perkmann, T., Fae, I., Wenda, S. Fuhrer, H., Henning, R., Valenta, R., & Pickl, W. F. (2020). Immunological imprint of COVID‐19 on human peripheral blood leukocyte populations, Allergy, 76 (3), p. 751-765.
Kucharski, A. J., Russell, T. W., Diamond, C., Liu, Y., Edmunds, J., Funk, S., & Eggo, R. M. Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The lancet Infectious Diseases, 20 (5), p. 553-558.
Li, Z.; Wu, M.; Yao, J.; Guo, J.; Liao, X.; Song, S.; Li, J.; Duan, G.; Zhou, Y.; Wu, X.; Zhou, Z.; Wang, T.; Hu, M.; Chen, X.; Fu, Y.; Lei, C.; Dong, H.; Xu, C.; Hu, Y.; Han, M.; Zhou, Y.; Jia, H.; Chen, X.; Yan, J. (2020). Caution on Kidney Dysfunctions of COVID-19 Patients, MedRxiv, https://doi.org/10.1101/2020.02.08.20021212
Lima, A. A., Almeida, A. G. C. S., Nunes, I. C. M., Sarmento, P. A., & Alves, W. T. B. P. (2022). Complicações renais resultantes da infecção por SARS-CoV-2 em pessoas hospitalizadas com COVID-19: revisão de escopo, Pesquisa, Sociedade e Desenvolvimento, 11 (1), p. 1-15.
Lippi, G., Plebani, M., & Henry, B. M. (2020). Thrombocytopenia is associated with severe coronavirus disease 2019(COVID-19) infections: A meta-analysis. Clinica Chimica Acta, 506, p. 145-148.
Lippi, G., & Plebani, M. (2020). Laboratory abnormalities in patients with COVID-2019 infection, Clinical Chemistry and Laboratory Medicine, 58 (7), p. 1131-1134.
Lippi, G., Lavie, C. J., & Sanchis-Gomar, F. (2020). Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis, Progress in Cardiovascular Diseases, 63 (3), p. 390–391.
Liu, Y., Du, X., Chgen, J., Jin. Y., Peng, L., Wang, H. H. X., Luo, M., Chen, L., & Zhao, Y. (2020). Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19, Journal of Infection, 81 (1), p. 6-12.
Liu, F., Long, X., Zhang, B., Zhang, W., Chen, X., & Zhang, Z. (2020). ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection, Clinical Gastroenterology and Hepatology, 18 (9), p. 2128-2130. .
Lozano, Y., & Palacios, E. V. (2021). Factores asociados a la hospitalización de pacientes con COVID-19 en la Unidad de Cuidados Intensivos de una clínica em 2020. Horizonte Médico, 21 (1), e1379, https://doi.org/10.24265/horizmed.2021.v21n1.09.
Lv, Z., Wang, W., Qiao, B., Cui, X., Feng, Y., Chen, L., Ma, Q., & Liu, X. (2021). The prognostic value of general laboratory testing in patients with COVID-19, Journal of clinical laboratory analysis, 35 (2), p. 1-7.
Maguire, D., Woods, M., Richards, C., Dolan, R., Veitch, J. W., Sim, W. M., Kemmett, O. E. H., Milton, D. C., Randall, S. L. W., Bui, L. D., Goldmann, N., Cameron, A., Laird, B., Talwar, D., Godber, I., Davidson, A., & Mcmillan, D. C. (2020). Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection, Journal of translational medicine, 18 (354), p. 1-10.
Mcnabb-Baltar, J., Jin, D. X., Groverm, A. S., Redd, W. D., Zhou, J. C., Hathorn, K. E., Mccarty, T. R., Bazarbashi, A. N., Shen, L., & Chan, W. (2020). Lipase Elevation in Patients With COVID-19, The American Journal of Gastroenterology, 115 (8), p. 1286-1288.
Nardo, A. D., Gleixner, M. S., Bakail, M., Dixon, E. D., Lax, S. F., & Trauner, M. (2020). Pathophysiological mechanisms of liver injury in COVID-19, Liver International, 41 (1), p. 20-32.
Nogueira, S. A. R., Oliveira, S. C. S., Carvalho, A. F. M., Neves, J. M. C., Silva, L. S. V., Silva Junior, G. B., & Nobre, M. E. P. Renal changes and acute kidney injury in covid-19: a systematic review, Revista da Associação Médica Brasileira, 66 (2), p. 112-117..
Paula, H. I., Amorim, D. L. A. N., Gonzaga, G. M., Batista, J. S., Ferreira, F. S. B., & Xavier, F. D. (2021) Alterações Hematológicas da Covid-19, Brasília Médica, 58, p. 1-6.
Payen, D., Cravat, M., Maadadi, H., Didelot, C., Prosic, L., Dupuis, C., Losser, M. R., & Bittencourt, M. C. (2020). A Longitudinal Study of Immune Cells in Severe COVID-19 Patients, Frontiers in Immunology, 11, p. 1-12.
Pereira, A. F., Terra, A. K. A., Oliveira, C. H. S., Terra, M. C., Oliveira, C. M., Carvalho, L. P., Oliveira, S. C., Rotondo, K. O. L., Betelho, L. M., Oliveira, C. S., Camilo, F. F., Delmoro, A. C. L., & Salles, B. C. C. (2021). Alterações hematológicas e hemostasia na COVID-19: uma revisão de literatura. Research, Society and Development, 10 (11), p. 1-17.
Pirsalehi, A., Baghestani, A., Sanadgol. G., Shirini, D., Baerz, M. M., Abdi, S., Akbari, M. E., & Bashash, D. (2021). Differential alteration trend of white blood cells (WBCs) and monocytes count in severe and non-severe COVID-19 patients within a 7-day follow-up, Iranian Journal of Microbiology, 13 (1), p. 8–16.
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., & Tian, D. S. (2020). Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China, Clinical Infectious diseases, 71, p. 762–8.
Rother, E.T.(2007). Revisão sistemática X revisão narrativa. Acta Paul Enferm. 20 (2), 5-6.
Saini, R. K., Saini, N., Ram, S., Soni, S. L., Suri, V., Malhotra, P., Kaur, J., Verma, I., Sharma, S., & Zohmangaihi, D. (2020). COVID-19 associated variations in liver function parameters: a retrospective study, Postgraduate Medical Journal, 98, p. 91-97.
Santos, J. C. O., & Mendonça, M. A. O. (2015). Fatores predisponentes para lesão renal aguda em pacientes em estado crítico: revisão integrativa, Revista da Sociedade Brasileira de Clinica Médica, 13 (1), p. 69-74.
Schulte-Schrepping, J., Reusch, N., Paclik, D., Babler, K., Schlickeiser, S., Zhang, B.; Kramer, B., Krammer, T.; Brumhard, S., Bonaguro, L., Domenico, E., Wendisch, D., Grasshoff, M., Kapellos, T. S., Beckstette, M., Pecht, T., Saglam, A., Dietrich, O., Mei, H. E., Schulz, A. R., Conrad., C. Kunkel, D., Vafadarnejad, E., Xu, C., Horne, A., Herbert, M., Drews, A., Thibeault, C., Pfeiffer, M., Hippenstiel, S., Hocke, A., Muller-Redetzky, H., Heim, K., Machleidt, F., Uhrig, A., Jarcy, L. B., Jurgens, L., Stegemann, M., Glosenkamp, C. R., Volk, H., Goffnet, C., Raabe, J., Kaiser, K. M., Vinh, M. T., Rieke, G., Meisel, C., Ulas, T., Becker, M., Geffers, R., Witzenrath, M., Drosten, C., Suttorp, N., Kalle, C. V., Kurth, F., Handler, K., Schultze, J. L., Aschenbrenner, A, C., Li, Y., Nattermann, J., Sawitzki, B., Saliba, A., & Sander, E. (2020). Suppressive myeloid cells are a hallmark of 2 severe COVID-19, MedRxiv, https://doi.org/10.1101/2020.06.03.20119818
Schulte-Schrepping, J., Reusch, N., Paclik, D., Babler, K., Schlickeiser, S., Zhang, B.; Kramer, B., Krammer, T.; Brumhard, S., Bonaguro, L., Domenico, E., Wendisch, D., Grasshoff, M., Kapellos, T. S., Beckstette, M., Pecht, T., Saglam, A., Dietrich, O., Mei, H. E., Schulz, A. R., Conrad., C. Kunkel, D., Vafadarnejad, E., Xu, C., Horne, A., Herbert, M., Drews, A., Thibeault, C., Pfeiffer, M., Hippenstiel, S., Hocke, A., Muller-Redetzky, H., Heim, K., Machleidt, F., Uhrig, A., Jarcy, L. B., Jurgens, L., Stegemann, M., Glosenkamp, C. R., Volk, H., Goffnet, C., Raabe, J., Kaiser, K. M., Vinh, M. T., Rieke, G., Meisel, C., Ulas, T., Becker, M., Geffers, R., Witzenrath, M., Drosten, C., Suttorp, N., Kalle, C. V., Kurth, F., Handler, K., Schultze, J. L., Aschenbrenner, A, C., Li, Y., Nattermann, J., Sawitzki, B., Saliba, A., & Sander, E. (2020). Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment, Cell, 182 (6), p. 1419–1440.
Shah, S. J., Barish, P. N., Prasad, P. A., Kistler, A., Neff, N., Kamm, J., Li, L. M., Chiu, C. Y., Babik, J. M., Fang, M. C., Abe-Jones, Y., Alipanah, N., Alvarez, F. N., Botvinnik, O. B., Castaneda, G., Dadasovich, R. M., Davis, J., Deng, X. Derisi, J. L., Detweiler, A. M., Federman, S., Haliburton, J., Hao, S., Kerkhoff, A. D., Kumar, G. R., Malcolm, K. B., Mann, S. A., Martinez, S., Mary, R. K., Mick, E., Mwakibete, L., Najafi, N., Peluso, M. J., Phelps, M., Pisco, A. O., Ratnasiri, K., Rubio, L. A., Sellas, A., Sherwood, K. D., Sheu, J., Spottiswoode, N., Tan, M., Yu, G., Kangelaris, K. N., & Langelier, C. (2020). Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: A retrospective cohort study of patients with and without COVID-19, EClinicalMedicine, 27 (100518), p. 1-17.
Silvin, A., Chapuis, N., Dunsmore, G., Goubet, A. G., Dubuisson, A., Derosa, L., Almire, C., Henon, C., Kosmider, O., Droin, N., Rameau, P., Catelain, C., Alfaro, A., Dussiau, C., Friedrich, C., Sourdeau, E., Marin, N., Szwebel, T., Cantin, D., Mouthon, L., Borderie, D., Deloger, M., Bredel, D., Mouthon, L., Borderie, D., Deloger, M., Bredel, D., Mouraud, S., Drubay, D., Adrieu, M., Lhonneur, A., Saada, V., Stoclin, A., Willekens, C., Pommeret, F., Griscelli, F., Ng, L. G., Zhang, Z., Bost, P., Amit, I., Barlesi, F., Marabelle, A., Pene, F., Gachot, B., Andre, F., Zitvogel, L., Ginhoux, F., Fontenay, M., & Solary, E. (2020). Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe From Mild COVID-19, Cell, 182 (6), p. 1401–1418.
Su, H., Yang, M., Wan, C., Yi, L., Tang, F., Zhu, H., Yi, F., Yang, H., Fogo, A. B., Nie, X., & Zhang, C. (2020). Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China, Kidney International, 98 (1), p. 219–227.
Sun, S., Cai, X., Wang, H., He, G., Lin, Y., Lu, B., Chen, C., Pan, Y., & Hu, X. (2020). Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China, Clinica Chimica Acta, 507, p.174-180.
Tajbakhsh, A., Gheibi Hayat, S. M., Taghizadeh, H., Akbari, A., Inabadi, M., Savardashtaki, A., Johnston, T. P., & Sahebkar, A. (2021). COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up, Expert Review Of Anti-infect Therapy, 19 (3), p.345-357.
Tan, Y., Zhou, J., Zhou, Q., Hu, L., & Long, Y. (2021). Role of eosinophils in the diagnosis and prognostic evaluation of COVID‐19, Journal Medical Virology, 93 (2), p. 1105–1110.
Tang, N., Li, D., Wang, X., & Sun, Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, Journal of Thrombosis and Haemostasis, 18 (4), p. 844–847.
Verdoni, L., Mazza, A., Gervasoni, A., Martelli, L., Ruggeri, M., Ciuffreda, M., Bonanomu, E., & Dantiga, L. (2020). An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, Lancet, 395 (10239), p. 1771-1778.
Veira, L. M. F., Emery, E., & Andriolo, A. (2020). COVID-19: laboratory diagnosis for clinicians. An updating article, São Paulo Medical Journal, 138 (3), p. 259-266.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020a). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China, JAMA, 323 (11), p. 1061–1069.
Wang, F., Wang, J. N. H., Zhao, Q., Xiong, Y., Deng, L., Song, S., Ma, Z., Mo, P., & Zhang, Y. (2020b). Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia, The Journal of Infectious Diseases, 221 (11), p. 1762–1769.
Westmeier, J., Paniskaki, K., Karaköse, Z., Werner, T., Sutter, K., Dolff, S., Overbeck, M., Limmer. A., Liu, J., Zheng, X., Brenner, T., Berger, M. M., Witzke, O., Trilling, M., Lu, M., Yang, D., Babel, N., Westhoff, T., Dittmer, U., & Zelinskyy, G. (2020). Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients, mBio, 11 (5), p. 1-13.
World Health Organization. (2022). Weekly epidemiological update on COVID-19 - 22 March 2022. Geneva, World Health Organization, Edition 84
Xavier, A. R., Silva, J. S., Almeida, J. P. C. L., Conceição, J. F. F., Lacerda, G. S., & Kanaan, S. (2020). COVID-19: manifestações clínicas e laboratoriais na infecção pelo novo coronavirus, Jornal Brasileiro de Patologia e Medicina Laboratorial, 56, p. 1-9.
Ye, W., Chen, G., Li, X., Lan, X., Ji, C., Hou, M., Zhang, D., Zeng, G., Wang, Y., Xu, C., Lu, W., Cui, R., Cai, Y., Huang, H., & Yang, L. (2020). Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19, Respiratory Research, 21 (169), p. 1-7.
Zancanaro, V., Moura, T. R., Bellaver, E. H., & Javorski, J. M. (2021). Alterações nos parâmetros hematológicos e imunológicos observadas na infecção pelo sars-cov-2: uma revisão sistemática de literature, Brazilian Journal of Development, 7 (5), p. 50745-50758.
Zhang, J. J., Dong, X., Cao, Y. Y., Yuan, Y. D., Yang, Y. B., Yan, Y. Q., Akdis, C. A., & Gao, Y. D. (2020). Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China, Allergy, 75 (7), p. 1730-1741.
Zhang, S., Liu, Y., Whang, X., Yang, L., Li, H., Whang, Y., Liu, M., Zhao, X., Xie, Y., Yang, Y., Zhang, S., Fan, Z., Dong, J., Yuan, Z., Ding, Z., Zhang, Y., & Hu, L. (2020). SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19, Journal of Hematology and Oncology, 3 (120), p. 1-22.
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult patients hospitalized with COVID-19 in Wuhan, China: a retrospective cohort study, The Lancet, 395 (10229), p.1054-1062.
Zhou, Y., Fu, B., Zheng, X., Wang, D., Zhao, C., Qi, Y., Sun, R., Tian, Z., Xu, X., & Wei, H. (2020). Pathogenic T-Cells and Inflammatory Monocytes Incite Inflammatory Storms in Severe COVID-19 Patients, National Science Review, 7 (6), p. 998–1002.
Zhou, Z., Ren, L., Zhang, L., Zhong, J., Xiao, Y., Jia, Z., Guo, L., Yang, J., Wang, C., Jiang, S., Yang, D., Zhang, G., Li, H., Chen, F., Xu, Y., Chen, M., Gao, Z., Yang, J., Dong, J., Liu, B., Zhang, X., Wang, W., He, K., Jin, Q., Li, M., & Wang, J. (2020). Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients, Cell Host Microbe, 27 (6), p. 883-890.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Marcus Vinicius Alves Lima; Polliana Silva Rodrigues; João Otávio Ferreira Pereira; Caroline Felix da Silva Mota; Monica Nascimento Bittencourt; Winnie Revilane de Melo Marques; Cristina de Jesus Gomes; Luciana Machado de Castro; Idalina Sá de Oliveira; Elinete de Jesus Bispo; Ana Kerlei Afonso Silva; Laíza de Oliveira Almeida; Rafael de Carvalho Barreiros; Tatiane dos Santos Silva; Luciele Cristina Lange; Afrânio Ferreira Evangelista
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
